Related Experiment Video
Updated: Jan 27, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell Necrosis
Sonal S Tonapi1, Vaishali Pannu1, Janet E Duncan1
1Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ 85040, USA.
Abstract:
Spliceosomal dysregulation dramatically affects many cellular processes, notably signal transduction, metabolism, and proliferation, and has led to the concept of targeting intracellular spliceosomal proteins to combat cancer. Here we show that a subset of lymphoma cells displays a spliceosomal complex on their surface, which we term surface spliceosomal complex (SSC). The SSC consists of at least 13 core components and was discovered as the binding target of the non-Hodgkin's lymphoma-specific aptamer C10.36. The aptamer triggers SSC internalization, causing global changes in alternative splicing patterns that eventually lead to necrotic cell death. Our study reveals an exceptional spatial arrangement of a spliceosomal complex and defines it not only as a potential target of anti-cancer drugs, but also suggests that its localization plays a fundamental role in cell survival.
Insights
Researchers discovered a surface spliceosomal complex (SSC) on lymphoma cells. Targeting this complex with aptamers induces cell death, revealing a novel cancer therapy target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Spliceosomal dysregulation is implicated in cancer, driving interest in targeting intracellular spliceosomal proteins.
- Alternative splicing impacts critical cellular processes like signal transduction, metabolism, and proliferation.
Purpose of the Study:
- To investigate the novel finding of a spliceosomal complex located on the surface of lymphoma cells.
- To characterize the surface spliceosomal complex (SSC) and its role in cancer cell survival and death.
Main Methods:
- Discovery of the SSC through its identification as the binding target of the C10.36 aptamer.
- Analysis of SSC composition, involving at least 13 core spliceosomal components.
- Investigating the functional consequences of aptamer-mediated SSC internalization.
Main Results:
- A subset of lymphoma cells exhibits a surface spliceosomal complex (SSC).
- The aptamer C10.36 binds to SSC, triggering its internalization into the cell.
- Internalization of SSC leads to widespread alterations in alternative splicing patterns.
- These splicing changes ultimately result in necrotic cell death.
Conclusions:
- The study reveals an unprecedented spatial organization of a spliceosomal complex on the cell surface.
- The SSC represents a promising novel target for anti-cancer drug development, particularly for lymphoma.
- The localization of the SSC is crucial for cancer cell survival, offering new therapeutic strategies.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Cell-surface Signaling
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Induced Pluripotent Stem Cells

